[Federal Register Volume 59, Number 169 (Thursday, September 1, 1994)] [Unknown Section] [Page 0] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 94-21654] [[Page Unknown]] [Federal Register: September 1, 1994] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committee Meeting; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Antiviral Drugs Advisory Committee, which is scheduled for September 12 and 13, 1994. This meeting was announced in the Federal Register of August 22, 1994 (59 FR 43126). The amendment is being made to reflect a change in the agenda for the meeting. There are no other changes. This amendment will be announced at the beginning of the open portion of the meeting. FOR FURTHER INFORMATION CONTACT: Lee L. Zwanziger, Center for Drug Evaluation and Research (HFD-9), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-4695. SUPPLEMENTARY INFORMATION: In the Federal Register of August 22, 1994, FDA announced that a meeting of the Antiviral Drugs Advisory Committee would be held on September 12 and 13, 1994. On page 43126, in the third column, the ``Open committee discussion'' portion of this meeting is amended as follows: Open committee discussion. The committee will discuss issues relevant to early availability of drugs for life threatening diseases, including both expanded access programs and accelerated approval. Dated: August 26, 1994. Linda A. Suydam, Interim Deputy Commissioner for Policy. [FR Doc. 94-21654 Filed 8-29-94; 2:43 pm] BILLING CODE 4160-01-F